Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2000
Business Overview: Chemed operates through four primary segments: Roto-Rooter (plumbing and drain cleaning), Patient Care (hospice services), Service America (home services), and Cadre Computer. The company completed an Exchange Offer in February 2000, converting approximately 576,000 shares of capital stock into Mandatorily Redeemable Convertible Preferred Securities.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Service Revenues and Sales | $121,534,000 | $105,735,000 |
| Net Income | $4,902,000 | $5,355,000 |
| Earnings Per Share (Diluted) | $0.48 | $0.51 |
| Operating Income | $7,539,000 | $5,792,000 |
| Net Cash from Operating Activities | $9,768,000 | $4,487,000 |
| Cash and Cash Equivalents (End of Period) | $13,825,000 | $33,580,000 |
| Total Debt (Current + Long-term) | $94,939,000 | $N/A (Not explicitly aggregated in text) |
| Unused Lines of Credit | $96,600,000 | N/A |
Note: All figures in thousands except per share data.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 15% year-over-year, driven primarily by the Roto-Rooter segment which grew 20%.
- Net Income Decline: Net income decreased 8.5% to $4.9 million. This decline is primarily attributed to significantly lower investment gains in 2000 ($951,000) compared to 1999 ($3,068,000).
- Operating Performance: Income from operations increased 30% to $7.5 million, reflecting improved operating leverage and higher gross margins in the Roto-Rooter segment.
- Segment Margins:
- Roto-Rooter: Aftertax margin improved from 5.7% to 6.9%.
- Patient Care: Aftertax margin declined from 2.2% to 1.2% due to higher G&A and interest costs.
- Service America: Aftertax margin declined from 3.1% to 1.7% due to higher overtime and material costs.
- Capital Structure: Stockholders' equity decreased from $212 million to $199.5 million due to the reclassification of shares into the Chemed Capital Trust.
Outlook, Risks, and Management Commentary
- Acquisitions: The company acquired two Roto-Rooter businesses for $10.5 million in cash during Q1 2000. Results were not material to the quarter.
- Liquidity: Management considers liquidity satisfactory with $96.6 million in unused credit lines. Cash decreased by $3.5 million during the quarter due to investing activities (acquisitions and capex) exceeding operating cash flow.
- Vitas Healthcare Investment: Chemed holds a $27 million investment in Vitas Healthcare. As of March 31, 2000, $715,000 in preferred dividends are in arrears. Management is negotiating repayment terms or an extension of the redemption date (currently April 1, 2000). Management believes the investment is fully recoverable with no impairment.
- Trust Securities: The new Trust Securities pay a 7.4% annual distribution ($2.00 per security) and are convertible at $37 per share. They are currently anti-dilutive.
Investor Verification Checklist
- Vitas Healthcare Status: Verify the outcome of negotiations regarding the $715,000 in arrears and the April 1, 2000 redemption date.
- Investment Gains Volatility: Assess the sustainability of earnings given the significant drop in "Other income" from investment sales ($3.1M in 1999 vs. $0.95M in 2000).
- Segment Margin Pressures: Monitor the Patient Care and Service America segments for continued margin compression due to rising interest rates and labor/material costs.
- Debt Service: Review the impact of the new Trust Securities distributions ($288,000 in Q1) on future cash flows.